The Texas Original's Dark Chocolate Bites are the brand's first medical cannabis product made using Rick Simpson Oil (RSO) to position them as the perfect option for therapeutic use of cannabis. The RSO boasts a full-spectrum extract that could help to amplify the therapeutic benefits of the THC, while the bites themselves are crafted with 70% cacao Belgian dark chocolate. The RSO in the bites is sourced from the Blue Dream medical cannabis strain that's locally grown at the brand's medical cannabis facility to ensure purity and quality.
CEO Nico Richardson spoke on the Texas Original's Dark Chocolate Bites saying, "Our new Dark Chocolate Bites and other high-quality medical cannabis products are meticulously crafted and tested to ensure Texans receive the safest, most effective cannabis medicine in the state. We look forward to welcoming current and new patients into our San Antonio store and bringing relief to those suffering from chronic pain and other symptoms associated with PTSD, cancer, and hundreds of other conditions medical cannabis can aid."
Cacao-Rich Cannabis Bites
Texas Original's Dark Chocolate Bites Have 70% Cacao
Trend Themes
1. Therapeutic Cannabis Products - Exploring the intersection of cannabis and medical treatments through cacao-infused options for enriched therapeutic benefits.
2. Full-spectrum Extracts - Utilizing full-spectrum extracts like Rick Simpson Oil (RSO) to enhance the potential therapeutic effects of cannabis-based products.
3. Local Sourcing in Cannabis - Emphasizing the importance of locally sourced cannabis strains for purity and quality in medical cannabis formulations.
Industry Implications
1. Medical Cannabis - Innovating within the field of medical cannabis with cacao-based products designed to offer targeted therapeutic relief.
2. Chocolatiers - Exploring collaboration opportunities with cannabis producers to create premium chocolate products infused with therapeutic compounds.
3. Pharmaceuticals - Considering the potential of full-spectrum cannabis extracts like RSO in developing new medication formulations for enhanced therapeutic benefits.